1. Home
  2. BOSC vs LNAI Comparison

BOSC vs LNAI Comparison

Compare BOSC & LNAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo B.O.S. Better Online Solutions

BOSC

B.O.S. Better Online Solutions

HOLD

Current Price

$4.71

Market Cap

28.6M

ML Signal

HOLD

Logo Lunai Bioworks Inc.

LNAI

Lunai Bioworks Inc.

N/A

Current Price

$0.87

Market Cap

23.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BOSC
LNAI
Founded
1990
N/A
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.6M
23.2M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
BOSC
LNAI
Price
$4.71
$0.87
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
83.2K
294.4K
Earning Date
11-25-2025
02-18-2026
Dividend Yield
N/A
N/A
EPS Growth
35.29
N/A
EPS
0.51
N/A
Revenue
$48,333,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$8.87
N/A
Revenue Growth
19.49
N/A
52 Week Low
$3.25
$0.81
52 Week High
$6.72
$14.00

Technical Indicators

Market Signals
Indicator
BOSC
LNAI
Relative Strength Index (RSI) 50.03 N/A
Support Level $4.56 N/A
Resistance Level $4.83 N/A
Average True Range (ATR) 0.24 0.00
MACD 0.06 0.00
Stochastic Oscillator 68.49 0.00

Price Performance

Historical Comparison
BOSC
LNAI

About BOSC B.O.S. Better Online Solutions

BOS Better Online Solutions Ltd is a provider of Intelligent Robotics and Supply Chain solutions for enterprises. The company manages its business in three reportable divisions: the Intelligent Robotics segment, the RFID Division segment, and the Supply Chain Solutions segment. The majority of revenue derives from Supply Chain Solutions which distributes electro-mechanical components, mainly to customers in the aerospace, defense, and other industries, and is a supply chain service provider for aviation customers that seek a comprehensive solution to their components-supply needs. Geographically company derives the majority of its revenue from Israel.

About LNAI Lunai Bioworks Inc.

Lunai Bioworks Inc is a biopharmaceutical company. Through its subsidiaries, it is mainly focused on developing allogeneic cell and gene therapies to promote stronger immune system responses, potentially for long-term or life-long cancer remission in some of the deadliest cancers. The group is engaged in the development of RENB-DC11 and RENB-DC20 (potential cell therapeutic vaccine candidates for different types of cancer); a proprietary AI platform that analyzes genetics to provide earlier and more accurate cancer diagnosis; and machine learning pipelines that harmonize and analyze complex, heterogeneous datasets to uncover clinically actionable insights. The group's reportable segments are: RENB, BioSymetrics, and RENC. Geographically, it operates in the United States and Netherlands.

Share on Social Networks: